SEER Cancer Stat Facts: Bladder Cancer. National Cancer Institute. Bethesda, MD 2024 [cited 2024 8-Dec]. Available from: https://seer.cancer.gov/statfacts/html/urinb.html.

AmericanCancerSociety. Key Statistics for Bladder Cancer 2022 [updated 12-Jan-2022; cited 2022 23-Feb]. Available from: https://www.cancer.org/cancer/bladder-cancer/about/key-statistics.html.

Michaeli JC, Boch T, Albers S, Michaeli T, Michaeli DT (2022) Socio-economic burden of disease: Survivorship costs for bladder cancer. J Cancer Policy 32:100326

Article  PubMed  Google Scholar 

Liu X, Liu X, Wu Y, Wu Q, Wang Q, Yang Z et al (2017) MicroRNAs in biofluids are novel tools for bladder cancer screening. Oncotarget 8(19):32370

Article  PubMed  PubMed Central  Google Scholar 

PDQ® Screening and Prevention Editorial Board. PDQ Bladder and Other Urothelial Cancers Screening. Bethesda, MD: National Cancer Institute. Updated <07/30/2021>. Available at: https://www.cancer.gov/types/bladder/patient/bladder-screening-pdq. Accessed <04/09/2020>. [PMID: 26389218] [

Cumberbatch MG, Noon AP (2019) Epidemiology, aetiology and screening of bladder cancer. Trans Androl Urol 8(1):5

Article  Google Scholar 

Kutwin P, Konecki T, Borkowska EM, Traczyk-Borszyńska M, Jabłonowski Z (2018) Urine miRNA as a potential biomarker for bladder cancer detection–a meta-analysis. Central Eur J Urol 71(2):177

CAS  Google Scholar 

Babjuk M, Burger M, Capoun O, Cohen D, Compérat EM, Escrig JLD et al (2021) European association of urology guidelines on non–muscle-invasive bladder cancer (ta, T1, and carcinoma in situ). Eur Urol 81:75–94

Article  PubMed  Google Scholar 

Schaefer A, Stephan C, Busch J, Yousef GM, Jung K (2010) Diagnostic, prognostic and therapeutic implications of microRNAs in urologic tumors. Nat Rev Urol 7(5):286–297

Article  CAS  PubMed  Google Scholar 

Wang W, Yin Z (2017) Diagnostic value of long non-coding RNA H19, UCA1, and HOTAIR as promising biomarkers in human bladder cancer. Int J Clin Exp Pathol 10(12):11659

PubMed  PubMed Central  Google Scholar 

Bautista-Sánchez D, Arriaga-Canon C, Pedroza-Torres A, De La Rosa-Velázquez IA, González-Barrios R, Contreras-Espinosa L et al (2020) The promising role of miR-21 as a cancer biomarker and its importance in RNA-based therapeutics. Mol Ther-Nucl Acids 20:409–420

Article  Google Scholar 

Gan L, Zheng L, Zou J, Luo P, Chen T, Zou J et al (2024) MicroRNA-21 in urologic cancers: from molecular mechanisms to clinical implications. Front Cell Dev Biol 12:1437951

Article  PubMed  PubMed Central  Google Scholar 

Matsuzaki K, Fujita K, Jingushi K, Kawashima A, Ujike T, Nagahara A et al (2017) MiR-21-5p in urinary extracellular vesicles is a novel biomarker of urothelial carcinoma. Oncotarget 8(15):24668–24678

Article  PubMed  PubMed Central  Google Scholar 

Rizk MS, El-Hefnawy SM, Sultan SM, Torad HK, Ismail AE-HA, Fouda MN et al (2023) Biochemical and molecular study of extracellular MiR-21-5p and MiR-99-5p as diagnostic biomarkers of urothelial bladder carcinoma. Gene Reports. 32:101793

Article  CAS  Google Scholar 

Homami A, Ghazi F (2016) MicroRNAs as biomarkers associated with bladder cancer. Med J Islam Repub Iran 30:475

PubMed  PubMed Central  Google Scholar 

Lin H, Shi X, Li H, Hui J, Liu R, Chen Z et al (2021) Urinary Exosomal miRNAs as biomarkers of bladder Cancer and experimental verification of mechanism of miR-93-5p in bladder Cancer. BMC Cancer 21(1):1293

Article  CAS  PubMed  PubMed Central  Google Scholar 

Mamdouh S, Sherif H, Romeih M, Elesaily K (2023) Urine micro-RNA signature as a potential non-invasive diagnostic biomarker in bladder cancer. Asian Pac J Cancer Prev 24(1):121–131

Article  CAS  PubMed  PubMed Central  Google Scholar 

Strandgaard T, Nordentoft I, Birkenkamp-Demtröder K, Salminen L, Prip F, Rasmussen J et al (2024) Field Cancerization Is Associated with Tumor Development, T-cell Exhaustion, and Clinical Outcomes in Bladder Cancer. Eur Urol 85(1):82–92

Article  CAS  PubMed  Google Scholar 

Li X, Gheinani AH, Adam RM (2019) A multi-omics approach to understanding the field effect in bladder cancer. Transl Androl Urol 8(6):775–778

Article  PubMed  PubMed Central  Google Scholar 

Rodden DJ, Chung EH, Pittie R, Miyamoto DT (2024) Imposter among us: field cancerization in the bladder. Transl Androl Urol 13(7):1319–1323

Article  PubMed  PubMed Central  Google Scholar 

Thomsen MBH, Nordentoft I, Lamy P, Vang S, Reinert L, Mapendano CK et al (2017) Comprehensive multiregional analysis of molecular heterogeneity in bladder cancer. Sci Rep 7(1):11702

Article  PubMed  PubMed Central  Google Scholar 

Xie Y, Ma X, Chen L, Li H, Gu L, Gao Y et al (2017) MicroRNAs with prognostic significance in bladder cancer: a systematic review and meta-analysis. Sci Rep 7(1):1–12

Google Scholar 

Tao J, Lu Q, Wu D, Li P, Xu B, Qing W et al (2011) microRNA-21 modulates cell proliferation and sensitivity to doxorubicin in bladder cancer cells. Oncol Rep 25(6):1721–1729

CAS  PubMed  Google Scholar 

Chen C, Ridzon DA, Broomer AJ, Zhou Z, Lee DH, Nguyen JT et al (2005) Real-time quantification of microRNAs by stem–loop RT–PCR. Nucleic Acids Res 33(20):e179

Article  PubMed  PubMed Central  Google Scholar 

Catto JW, Miah S, Owen HC, Bryant H, Myers K, Dudziec E et al (2009) Distinct microRNA alterations characterize high-and low-grade bladder cancer. Can Res 69(21):8472–8481

Article  CAS  Google Scholar 

Catto JW, Alcaraz A, Bjartell AS, White RDV, Evans CP, Fussel S et al (2011) MicroRNA in prostate, bladder, and kidney cancer: a systematic review. Eur Urol 59(5):671–681

Article  CAS  PubMed  Google Scholar 

Drakaki A, Koutsioumpa M, O'Brien NA, Vorvis C, Iliopoulos D, Slamon DJ. A chemically-modified miR-21 inhibitor (ADM-21) as a novel potential therapy in bladder cancer. American Society of Clinical Oncology; 2017.

Mitash N, Agnihotri S, Tiwari S, Agrawal V, Mandhani A (2017) MicroRNA-21 could be a molecular marker to predict the recurrence of nonmuscle invasive bladder cancer. Indian J Urol 33(4):283–290

Article  PubMed  PubMed Central  Google Scholar 

Dyrskjøt L, Ostenfeld MS, Bramsen JB, Silahtaroglu AN, Lamy P, Ramanathan R et al (2009) Genomic profiling of microRNAs in bladder cancer: miR-129 is associated with poor outcome and promotes cell death in vitro. Can Res 69(11):4851–4860

Article  Google Scholar 

Zaravinos A, Radojicic J, Lambrou GI, Volanis D, Delakas D, Stathopoulos EN et al (2012) Expression of miRNAs involved in angiogenesis, tumor cell proliferation, tumor suppressor inhibition, epithelial-mesenchymal transition and activation of metastasis in bladder cancer. J Urol 188(2):615–623

Article  CAS  PubMed  Google Scholar 

Neely LA, Rieger-Christ KM, Neto BS, Eroshkin A, Garver J, Patel S et al (2010) A microRNA expression ratio defining the invasive phenotype in bladder tumors. Urol Oncol: Semin Origin Invest 28:39–48

Article  CAS  Google Scholar 

Usuba W, Urabe F, Yamamoto Y, Matsuzaki J, Sasaki H, Ichikawa M et al (2019) Circulating miRNA panels for specific and early detection in bladder cancer. Cancer Sci 110(1):408–419

Article  CAS  PubMed  Google Scholar 

Ghorbanmehr N, Gharbi S, Korsching E, Tavallaei M, Einollahi B, Mowla SJ (2019) miR-21-5p, miR-141-3p, and miR-205-5p levels in urine—promising biomarkers for the identification of prostate and bladder cancer. Prostate 79(1):88–95

Article  CAS  PubMed  Google Scholar 

Sapre N, Macintyre G, Clarkson M, Naeem H, Cmero M, Kowalczyk A et al (2016) A urinary microRNA signature can predict the presence of bladder urothelial carcinoma in patients undergoing surveillance. Br J Cancer 114(4):454–462

Article  CAS  PubMed  PubMed Central  Google Scholar 

Mobarra N, Raji S, Najafi S, Kafi FK, Ferns GA, Pakzad R. Hypoxia-Induced miR-210 Overexpression Promotes the Differentiation of Human-Induced Pluripotent Stem Cells to Hepatocyte-Like Cells on Random Nanofiber Poly-L-Lactic Acid/Poly (ε-Caprolactone) Scaffolds. Oxidative medicine and cellular longevity. 2021;2021.

Smithb PJMSG, Adcockc ALDIM, Greened NGMCM. The Estrogen-Induced miR-19 Downregulates Secretory Leucoprotease Inhibitor Expression in Monocytes. 2019.

Ribas J, Ni X, Haffner M, Wentzel EA, Salmasi AH, Chowdhury WH et al (2009) miR-21: an androgen receptor–regulated microRNA that promotes hormone-dependent and hormone-independent prostate cancer growth. Can Res 69(18):7165–7169

Article  CAS  Google Scholar